A cis-acting element in the 3'-untranslated region of human TNF-α mRNA renders splicing dependent on the activation of protein kinase PKR

Genes and Development

Volumn 13, Issue 24, 1999, Pages 3280-3293

  Osman, Farhat ^a   Jarrous, Nayef ^a   Ben Asouli, Yitzhak ^a   Kaempfer, Raymond ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

3' untranslated region; Cis acting RNA element; Protein kinase PKR; Splicing; Tumor necrosis factor

Indexed keywords

CYTOKINE; MESSENGER RNA; PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; RNA BINDING; RNA SPLICING; RNA STRUCTURE;

2-AMINOPURINE; 3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CRICETINAE; EIF-2 KINASE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PROTEIN BIOSYNTHESIS; RECOMBINANT FUSION PROTEINS; RNA SPLICING; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033572827     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.24.3280     Document Type: Article

References (55)

1. Allmang, C. and D. Tollervey. 1998. The role of the 3′ external transcribed spacer in yeast pre-rRNA processing. J. Mol. Biol. 278: 67-78.
2. Bauren, G. and L. Wieslander. 1994. Splicing of Balbiani ring 1 gene pre-mRNA occurs simultaneously with transcription. Cell 76: 183-192.
3. Besse, S., D. Rebouillat, I. Marie, F. Puvion Dutilleul, and A.G. Hovanessian. 1998. Ultrastructural localization of interferon-inducihle double-stranded RNA-activated enzymes in human cells. Exp. Cell Res. 239: 379-392.
4. Bevilacqua, P.C. and T.R. Cech. 1996. Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry 35: 9983-9994.
5. Bevilacqua, P.C., C.X. George, C.E. Samuel, and T.R. Cech. 1998. Binding of the protein kinase PKR to RNAs with secondary structure defects: Role of the tandem A-G mismatch and noncontiguous helixes. Biochemistry 37: 6303-6316.
6. Caceres, J.F., G.R. Screaton, and A.R. Krainer. 1998. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes & Dev. 12: 55-66.
7. Chu, W.M., R. Ballard, B.W. Carpick, B.R. Williams, and C.W. Schmid. 1998. Potential Alu function: Regulation of the activity of double-stranded RNA-activated kinase PKR. Mol. Cell. Biol. 18: 58-68.
8. Circle, D.A., O.D. Neel, H.D. Robertson, P.A. Clarke, and M.B. Mathews. 1997. Surprising specificity of PKR binding to delta agent genomic RNA. RNA 3: 438-448.
9. Clarke, P.A. and M.B. Mathews. 1995. Interactions between the double-stranded RNA binding motif and RNA: Definition of the binding site for the interferon-induced protein kinase DAI (PKR) on adcnovirus VA RNA. RNA 1: 7-20.
10. Colwill, K., T. Pawson, B. Andrews, J. Prasad, J.L. Manley, J.C. Bell, and P.I. Duncan. 1996. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J. 15: 265-267.
11. Davis, S. and J.C. Watson. 1996. In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3′ untranslated regions of human alpha-tropomyosin. Proc. Natl. Acad. Sci. 93: 508-513.
12. Der, S.D., Y.L. Yang, C. Weissmann, and B.R. Williams. 1997. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. 94: 3279-3283.
13. Donze, O., R. Jagus, A.E. Koromilas, J.W.B. Hershey, and N. Sonenberg. 1995. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 14: 3828-3834.
14. English, B.K., W.M. Weaver, and C.B. Wilson. 1991. Differential regulation of lymphotoxin and tumor necrosis factor genes in human T lymphocytes. J. Biol. Chem. 266: 7108-7113.
15. Farrell, P.J., K. Balkow, T. Hunt, R.J. Jackson, and H. Trachsel. 1977. Phosphorylation of initiation factor eIF-2 and the control of reticulocyte protein synthesis. Cell 11: 187-200.
16. Gerez, L., G. Arad, S. Efrat, M. Ketzinel, and R. Kaempfer. 1995. Post-transcriptional regulation of human interleukin-2 gene expression at processing of precursor transcripts. J. Biol. Chem. 270: 19569-19575.
17. Goldfeld, A.E., C. Doyle, and T. Maniatis. 1990. Human tumor necrosis factor α gene regulation by virus and lipopolysaccharide. Proc. Natl. Acad. Sci. 87: 9769-9773.
18. Gorman, C.M., L.F. Mofat, and B.H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044-1051.
19. Gui, J.F., W.S. Lane, and X.D. Fu. 1994. A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 369: 678-682.
20. Han, J., T. Brown, and B. Beutler. 1990. Endotoxin-responsive sequences control cachectin-tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171: 465-475.
21. Han, J., G. Huez, and B. Beutler. 1991. Interactive effects of the tumor necrosis factor promoter and 3′ untranslated regions. J. Immunol. 146: 1843-1848.
22. Hershey, J.W.B. 1991. Translational control in mammalian cells. Annu. Rev. Biochem. 60: 717-755.
23. Hu, Y. and T.W. Conway. 1993. 2-Aminopurine inhibits the double-stranded RNA-dependent protein kinase both in vitro and in vivo. J. Interferon Res. 13: 323-328.
24. Jarrous, N. and R. Kaempfer. 1994. Induction of human interleukin-1 gene expression by retinoic acid and its regulation at processing of precursor transcripts. J. Biol. Chem. 269: 23141-23149.
25. Jarrous, N., F. Osman, and R. Kaempfer. 1996. 2-Aminopurine selectively inhibits splicing of tumor necrosis factor-α mRNA. Mol. Cell. Biol. 16: 2814-2822.
26. Jeffrey, I.W., S. Kadereit, E.F. Meurs, T. Metzger, M. Bachmann, M. Schwemmle, A.G. Hovanessian, and M.J. Clemens. 1995. Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp. Cell. Res. 218: 17-27.
27. Kanopka, A., O. Muhlemann, S. Petersen-Mahrt, C. Estmer, C. Ohrmalm, and G. Akusjarvi. 1998. Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature 393: 185-187.
28. Koromilas, A.E., S. Roy, G.N. Barber, M.G. Katze, and N. Sonenberg. 1992. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257: 1685-1689.
29. Koromilas, A. E., C. Cantin, A. W. Craig, R. Jagus, J. Hiscott, and N. Sonenberg. 1995. The interferon-inducible protein kinase PKR modulates the transcriptional activation of immunoglobulin kappa gene. J. Biol. Chem. 270: 25426-25434.
30. Kumar, A., Y.L. Yang, V. Flati, S. Der, S. Kadereit, A. Deb, J. Haque, L. Reis, C. Weissmann, and B.R. Williams. 1997. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF-1 and NF-kappaB. EMBO J. 16: 406-416.
31. Maitra, R.K., N.A. McMillan, S. Desai, J. McSwiggen, A.G. Hovanessian, G. Sen, B.R. Williams, and R.H. Silverman. 1994. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204: 823-827.
32. Meurs, E.F., J. Galabru, G.N. Barber, M.G. Katze, and A.G. Hovanessian. 1993. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. 90: 232-236.
33. Misteli, T., J.F. Caceres, and D.L. Spector. 1997. The dynamics of a pre-mRNA splicing factor in living cells. Nature 387: 523-527.
34. Mundschau, L.J. and D.V. Faller. 1995. Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. J. Biol. Chem. 270: 3100-3106.
35. Nagai, K., A.H. Wong, S. Li, W.N. Tam, A.R. Cuddihy, N. Sonenberg, M.B. Mathews, J. Hiscott, M.A. Wainberg, and A.E. Koromilas. 1997. Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR. J. Virol. 71: 1718-1722.
36. Nedwin, G.E., S.L. Naylor, A.Y. Akaguchi, D. Smith, J. Jarrett-Nedwin, D. Pennica, D.V. Goeddel, and P.W. Gray. 1985. Human lymphotoxin and tumor necrosis factor genes: Structure, homology and chromosomal localization. Nucleic Acids Res. 13: 6361-6373.
37. Neel, H., P. Gondran, D. Weil, and F. Dautry. 1995. Regulation of pre-mRNA processing by src. Curr. Biol. 5: 413-422.
38. Neugebauer, K.M. and M.B. Roth. 1997. Distribution of pre-mRNA splicing factors at sites of RNA polymerase II transcription. Genes & Dev. 11: 1148-1159.
39. Robertson, H.D. and M.B. Mathews. 1996. The regulation of the protein kinase PKR by RNA. Biochimie 78: 909-914.
40. Robertson, H.D., L. Manche, and M.B. Mathews. 1996. Paradoxical interactions between human delta hepatitis agent RNA and the cellular protein kinase PKR. J. Virol 70: 5611-5617.
41. Rosen, H., S. Knoller, and R. Kaempfer. 1981. Messenger RNA specificity in the inhibition of eukaryotic translation by double-stranded RNA. Biochemistry 20: 3011-3020.
42. Samuel, C.E. 1993. The eIF-2α protein kinase, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268: 7603-7606.
43. Schmedt, C., S.R. Green, L. Manche, D.R. Taylor, Y. Ma, and M.B. Mathews. 1995. Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J. Mol. Biol. 249: 29-44.
44. Srivastava, S.P., K.U. Kumar, and R.J. Kaufman. 1998. Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J. Biol. Chem. 273: 2416-2423
45. St-Johnston, D., N.H. Brown, J.G. Gall, and M. Jantsch. 1992. A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. 89: 10979-10988.
46. Tanaka, H. and C.E. Samuel. 1994. Mechanism of interferon action. Structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc. Natl. Acad. Sci. 91: 7995-7999.
47. Thomis, D.C. and C.E. Samuel. 1993. Mechanism of interferon action: Evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR. J. Virol. 67: 695-700.
48. Umlauf, S.W., B. Beverly, O. Lantz, and R.H. Schwartz. 1995. Regulation of interleukin-2 gene expression by CD28 co-stimulation in mouse T-cell clones: Both nuclear and cytoplasmic RNAs are regulated with complex kinetics. Mol. Cell. Biol. 15: 3197-3205.
49. Wathelet, M.G., I.M. Clauss, F.C. Paillard, and G.A Huez. 1989. 2-Aminopurine selectively blocks the transcriptional activation of cellular genes by virus, double-stranded RNA and interferons in human cells. Eur. J. Biochem. 184: 503-509.
50. Weil, D., S. Brosset, and F. Dautry. 1990. RNA processing is a limiting step for murine tumor necrosis factor β expression in response to interleukin-2. Mol. Cell. Biol. 10: 5865-5875.
51. Wong, G.H.W. and D.V. Goeddel. 1986. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323: 819-822.
52. Wu, S. and R.J. Kaufman. 1997. A model for the double-stranded RNA (dsRNA)-dependent dimerization and activation of the dsRNA-activated protein kinase PKR. J. Biol. Chem. 272: 1291-1296.
53. Yang, Y., J.F. Chang, J.R. Parnes, and C.G. Fathman. 1998. T cell receptor (TCR) engagement leads to activation-induced splicing of tumor necrosis factor (TNF) nuclear pre-mRNA. J. Exp. Med. 188: 247-254.
54. Yeung, M.C., J. Liu, and A.S. Lau. 1996. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc. Nat. Acad. Sci. 93: 12451-12455.
55. Zuker, M. 1989. On finding all suboptimal foldings of an RNA molecule. Science 244: 48-52.